Acetyl tetrapeptide-5
is used in cosmetic eye formulations to decrease puffiness, eye bags, and dark circles by reducing edema and protecting proteins such as SOD from glycation
Alanine
Ala / A · hydrophobic residue · neutral charge
AOD-9604
is studied as an anti-obesity peptide that can reduce weight gain and increase fat oxidation in obese animal models with generally neutral effects on IGF-1 and glucose metabolism in early human trials
Arginine
Arg / R · basic residue · positive charge
Argireline
is a topical cosmetic peptide reported to decrease dynamic wrinkles by partially mimicking the mechanism of botulinum toxin in a non-invasive manner
Asparagine
Asn / N · polar residue · neutral charge
Aspartic acid
Asp / D · acidic residue · negative charge
BPC-157
is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects
Comparison
While Dulaglutide is a once-weekly GLP-1RA for type 2 diabetes that lowers HbA1c and body weight by enhancing glucose-dependent insulin secretion and reducing appetite6668, Ipamorelin is investigated for producing moderate, physiologic-like GH pulses useful for studying anabolic, body-composition, and recovery effects with a relatively clean endocrine side-effect profile compared with earlier GHRPs16.
While Dulaglutide works as a recombinant fusion protein consisting of two disulfide-linked GLP-1(7–37) analogs each covalently fused via a linker to an IgG4 Fc fragment, yielding a large, long-acting GLP-1 receptor agonist protected from DPP-4 degradation66, Ipamorelin is a third-generation pentapeptide growth hormone secretagogue that selectively agonizes the ghrelin (GHSR-1a) receptor to trigger controlled, GH-specific pituitary release with minimal effects on cortisol or prolactin16269596.
Dulaglutide
GCG
Ipamorelin
GHSR
Both peptides fall into a similar broad context as Hormone peptides, although the details of how they are used and discussed still diverge. Both are often discussed in Metabolic and endocrine contexts, while Dulaglutide is more of a metabolic peptide and Ipamorelin is better described as a hormone peptide. Both appear to work through Receptor agonist, but the functional emphasis still separates, with Dulaglutide leaning toward Metabolic regulation and Ipamorelin leaning toward Anabolic growth and Lipolysis and fat loss. Dulaglutide has a more engineered peptide origin, while Ipamorelin is closer to synthetic design background and their development context also differs, with Dulaglutide approved while Ipamorelin is in Preclinical development. Dulaglutide takes the form of a peptide conjugate, whereas Ipamorelin is closer to a linear peptide, Ipamorelin incorporates d-amino acid substitution and amidation features that are not part of Dulaglutide; while their sequence patterns also diverge, with Dulaglutide showing alpha-helical domain features and Ipamorelin showing protein-mimetic sequence features.